Status:
UNKNOWN
Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer Detection
Lead Sponsor:
Medical University of Vienna
Conditions:
Gd-based Contrast Media Exposure During Breast MRI Scans
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Purpose: To determine whether patients at high risk to develop breast cancer having received at least 6 cumulative dosages of macrocyclic Gd-based contrast media in the context of breast cancer screen...
Eligibility Criteria
Inclusion
- Female; cumulative exposure to ≥6 dosages of macrocyclic Gd-based agents in the course of breast MRI screening for breast cancer OR no exposure to Gd-based contrast media
Exclusion
- Previous chemotherapy; serious illness including cardiovascular and neurological diseases; contraindications to MRI; exposure to non-macrocyclic Gd-based contrast agents
Key Trial Info
Start Date :
November 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03393442
Start Date
November 25 2017
End Date
April 1 2018
Last Update
January 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090